Selected article for: "common variable immunodeficiency and variable immunodeficiency"

Author: Saghazadeh, Amene; Rezaei, Nima
Title: Pulmonary Manifestations of Predominantly Antibody Deficiencies
  • Cord-id: 0qxzpvm2
  • Document date: 2019_1_1
  • ID: 0qxzpvm2
    Snippet: Predominantly antibody deficiencies (PADs) are the most frequent forms of primary immunodeficiency diseases (PIDs). Commonly accompanied with complications involving several body systems, immunoglobulin substitution therapy along with prophylactic antibiotics remained the cornerstone of treatment for PADs and related complications. Patients with respiratory complications should be prescribed an appropriate therapy as soon as possible and have to be adhering to more and longer medical therapies.
    Document: Predominantly antibody deficiencies (PADs) are the most frequent forms of primary immunodeficiency diseases (PIDs). Commonly accompanied with complications involving several body systems, immunoglobulin substitution therapy along with prophylactic antibiotics remained the cornerstone of treatment for PADs and related complications. Patients with respiratory complications should be prescribed an appropriate therapy as soon as possible and have to be adhering to more and longer medical therapies. Recent studies identified a gap for screening protocols to monitor respiratory manifestations in patients with PADs. In the present chapter, the pulmonary manifestations of different PADs for each have been discussed. The chapter is mainly focused on X-linked agammaglobulinemia, common variable immunodeficiency, activated PI3K-δ syndrome, LRBA deficiency, CD19 complex deficiencies, CD20 deficiency, other monogenic defects associated with hypogammaglobulinemia, immunoglobulin class switch recombination deficiencies affecting B-cells, transient hypogammaglobulinemia of infancy, and selective IgA deficiency.

    Search related documents:
    Co phrase search for related documents
    • abnormal activity and acute lymphoblastic leukemia: 1
    • abnormal activity and acute pneumonia: 1
    • abnormal chest and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • abnormal chest and acute infection incidence: 1
    • abnormal chest and acute lung injury: 1
    • abnormal chest and acute lymphoblastic leukemia: 1
    • abnormal chest and acute pneumonia: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abnormal chest and acute pulmonary function: 1
    • activation expression and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activation expression and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • activation expression and acute pneumonia: 1, 2, 3, 4
    • activation expression and adaptive immune response: 1, 2, 3
    • activation induce and acute infection: 1, 2, 3, 4, 5
    • activation induce and acute lung injury: 1, 2
    • activation induce and acute pneumonia: 1
    • activation induce and adaptive immune response: 1, 2, 3, 4
    • acute infection and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and adaptive immune response: 1, 2, 3, 4, 5
    • acute pneumonia and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8